|
US2009176798A1
|
|
New compounds III
|
|
US2008096873A1
|
|
Aryl sulfonamide compounds for treating obesity
|
|
EA016456B1
|
|
8-sulfonyl-1,3,4,8-tetrahydro-2h-[1,4]oxazepino[6,7-e]indole derivatives and their use as 5-htreceptor ligands
|
|
AU2007205749A1
|
|
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
BRPI0713328A2
|
|
pyridine and pyrazine derivatives as mnk kinase inhibitors
|
|
WO2006122931A1
|
|
Beta-carboline derivatives and theri use as ghsr modulators
|
|
WO2006114402A1
|
|
Substituted octahydroisoindoles as antagonists of melanin concentrating hormone receptor 1 (mch1r)
|
|
WO2006067063A2
|
|
Screening methods for identification of modulators of cytokine class i
|
|
WO2006062481A1
|
|
New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
|
|
WO2006001770A1
|
|
Method for identifying modulators of cytokine class i receptor
|
|
ZA200504712B
|
|
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
|
|
US2007281938A1
|
|
Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
|
|
TW200530206A
|
|
New compounds
|
|
WO2005068646A1
|
|
Methods for the protein production and purification of soluble recombinant polypeptides
|
|
ZA200603617B
|
|
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-HT6 receptor-related disorder
|
|
CA2545506A1
|
|
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
|
|
CA2552583A1
|
|
Improved synthesis of 2-substituted adenosines
|
|
WO2005048916A2
|
|
Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
|
|
WO2005051381A1
|
|
Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)
|
|
WO2005051380A1
|
|
Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r)
|
